GAMMA Investing’s Cymabay Therapeutics CBAY Stock Holding History

GAMMA Investing’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-220	Closed	-$5.17K	–	3383
2023 Q4	$5.17K	Buy	+220	New	+$3.92K	﹤0.01%	2230

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMMA Investing's CBAY Position: Q1 2024 in Review

GAMMA Investing sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 220 shares — an estimated $5.17K sold.

GAMMA Investing first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $5.17K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

GAMMA Investing reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
GAMMA Investing sold 220 Cymabay Therapeutics shares in Q1 2024, an estimated $5.17K.
GAMMA Investing first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
GAMMA Investing's Cymabay Therapeutics position peaked at $5.17K in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on GAMMA Investing's 13F filing for Q1 2024, filed 5 Apr 2024.